BioLife Solutions Stock News

One of its acquired companies, Sterling, could not cope with the rapidly rising demand and this generated substantial one-off costs, marring the figures.

BioLife Solutions, Inc. (NASDAQ: BLFS) Q4 2021 earnings call dated Feb. 28, 2022 Corporate Participants: Troy Wichterman — Chief Financial Officer Michael Rice — Chairman and Chief Executive Officer Rod de Greef — Chief Operating Officer […] The post BioLife Solutions, Inc. (BLFS) Q4 2021 Earnings Call Transcript first appeared on AlphaStreet .

BOTHELL, Wash., March 1, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and servic

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of -131.25% and 0.06%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the s

BioLife Solutions, Inc. (BLFS) CEO Mike Rice on Q4 2021 Results - Earnings Call Transcript

BioLife Solutions press release (BLFS): Q4 GAAP EPS of -$0.37 misses by $0.20.Revenue of $37.3M (+153.7% Y/Y) beats by $0.87M.Initial guidance for 2022 total revenue at $159.5…

BOTHELL, Wash., Feb. 28, 2022 /PRNewswire/ -- BioLife Solutions, Inc. , a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies… | February 28, 2022

BOTHELL, Wash., Feb. 28, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies (CGT) and the broader biopharma markets, today…

BioLife Solutions, Inc. (BLFS) delivered earnings and revenue surprises of -131.25% and 0.06%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the s

BOTHELL, Wash., Feb. 21, 2022 /PRNewswire/ --  BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") an

PETQ vs. BLFS: Which Stock Is the Better Value Option?

PETQ vs. BLFS: Which Stock Is the Better Value Option?

Try your hand at morphing science and business for a great investment opportunity in biotech.

BioLife Solution is enjoying robust growth years over years.